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Abstract
Background: To identify early symptoms of familial adenomatous polyposis with a view to
improve early diagnosis and treatment. Diagnosis on the basis of genetic testing is usually limited
to where there is a known family history, so FAP is more usually diagnosed on clinical grounds.
Except for those identified via FAP registers, the majority of patients are symptomatic at the time
of diagnosis.
Methods: We undertook a retrospective study of 143 FAP patients treated at the Department of
Surgery, University of Erlangen between 1971 and 2000. We identified patterns of symptoms,
endoscopic findings and extracolonic manifestations in three age groups.
Results: FAP was diagnosed clinically on the basis of symptoms in 84% (120/143) of these patients.
Most presented with intestinal symptoms such as colonic bleeding (68%) and diarrhea (42%). All
but one of the patients between 20 and 40 years old had rectal polyps (98.7%, 75/76), whereas in
those over 40 years old the prevalence was 76% (35/46). Non-specific symptoms such as abdominal
pain, fatigue and bloating were less frequent and were mainly reported by patients older than 40.
Conclusion: The commonest presenting features of FAP are alteration of bowel habit and rectal
bleeding, but both are found in many other conditions. Patients with these findings need immediate
endoscopy to allow prompt diagnosis and prophylactic surgery.
Background
Familial adenomatous polyposis (FAP) is an autosomal
dominantly inherited disease and is caused by germline
mutations in the adenomatous polyposis coli gene (APC)
in chromosome 5q21 [1]. Somatic mutations of the APC
gene occur in about 80% of sporadic colorectal cancers.
APC encodes for a multimodal protein that plays an
important role in the wnt-signalling pathway and in inter-
cellular adhesion [2,3]. The APC germline mutation has a
penetrance which is close to 100% [4]. Untreated, the dis-
ease usually leads to the appearance of hundreds of ade-
nomatous polyps in the colorectum between puberty and
age 20 and to cancer by the early forties at the latest which
is the most frequent reason for death in patients with FAP
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notype. AFAP with less than 100 adenomatous polyps is
diagnosed at a mean age of 44 years, and cancer is diag-
nosed at a mean age of 56 years [6]. Congenital hypertro-
phy of retinal pigment epithelium, upper gastrointestinal
polyps, desmoid tumors, adrenal adenomas and osteo-
mas are extracolonic FAP phenotypic features whose
expression depends upon the mutated region of the APC
gene [7-11].
The incidence of FAP is approximately 1 in 8000 [12].
Early detection, prophylactic surgery and lifelong surveil-
lance are essential to prevent the development of colorec-
tal cancer [13]. When an index patient is newly diagnosed
in a center with an established FAP register, screening of
family members with molecular diagnostics is carried out
as a matter of routine and can detect the condition before
the development of symptoms. It is rare for patients out-
side this system to be diagnosed prior to the development
of symptoms. Also in patients with spontaneous new
mutations of the APC gene, early clinical diagnosis can
increase their descendants' chance of survival. Lack of
awareness and the absence of systematic family screening
may cause diagnosis to be delayed in patients at risk of
inherited colorectal cancer [14]. According to the litera-
ture, new mutations occur in 25% of all FAP cases and this
predominantly young patient population is burdened
with a high risk of colorectal cancer. It is therefore desira-
ble that there are defined clinical algorithms for detecting
the characteristic clinical signs of FAP, ideally within a
multidisciplinary setting in which patients are entered on
an FAP register.
In a retrospective analysis, we evaluated all clinical symp-
toms of FAP prior to surgery. We categorized these accord-
ing to patient age and into colorectal and extracolonic
manifestations of the disease. Our aim was to detect spe-
cific characteristics in each age group which could lead to




The diagnosis of FAP was established clinically if more
than 100 polyps were detected endoscopically in the
colorectum.
Patient population
Between 1971 and 2000, we registered 157 patients (66
women, 85 men, 6 unknown) with an endoscopic diag-
nosis of FAP. The mean age at primary diagnosis was 34
(± 15 SD) years with a range of 5 to 73 years. In 151 cases,
surgery was performed. Sixty-seven patients had colec-
tomy with ileorectal anastomosis, 55 patients underwent
restorative proctocolectomy with ileal pouch-anal anasto-
mosis, and 10 had proctocolectomy with an end-ileos-
tomy. Nineteen patients underwent various other surgical
procedures. Presently, 83 patients remain alive and 28
patients have been lost to follow-up. Forty patients are
known to have died: 20 of colorectal cancer, 5 due to
desmoid tumors, 10 of other causes and 5 for unknown
reasons.
A predominant early symptom could be defined and doc-
umented in 143 patients. Family screening revealed that
29 of these patients had affected relatives, while no FAP
was detected in the families of the remaining 114 patients.
Evaluation of symptoms
The predominant symptoms of FAP were analyzed and
documented retrospectively in all 143 cases. The entire
patient population was divided into three age groups
according the time of primary diagnosis: less than 20, 20
to 40, and more than 40 years of age. Abdominal pain,
pain during defecation, bloating, fatigue and loss of
weight were categorized as non-specific symptoms (figure
1). Colonic bleeding, anemia, mucous discharge,
diarrhea, paradoxical diarrhea and constipation were cat-
egorized as bleeding and stool disorders (figure 2).
Evaluation of colorectal and extracolonic manifestations
The endoscopic reports were obtained and the pattern of
polyps in the colorectum was divided into several groups:
no rectal polyps, less than 10 rectal polyps, 10–100 pol-
yps, and more than 100 polyps. We recorded the preva-
lence of carcinoma at the primary FAP diagnosis (table 1).
In addition, we documented any extracolonic manifesta-
tions of FAP: desmoid tumors (abdominal wall,
mesenteric, retroperitoneal), gastric polyps, duodenal
polyps and polyps of the small bowel (table 2).
Data presentation
The relative prevalence of symptoms in each age group is
shown in figures 1 and 2. Molecular findings are grouped
according to the mutations detected in the APC gene
(table 3). Colorectal and extracolonic manifestations at
primary diagnosis are presented for each of the recorded
symptoms. Values in brackets indicate the percentage of
affected patients in each subgroup (tables 1 and 2).
Results
Age and symptoms
The diagnosis of FAP was made on the basis of clinical
symptoms in 66% of patients (94/143). Diagnosis was
incidental in 6% (9/143) and the reasons are unknown in
8% (11/143).
Most patients (53%, 76/143) were between 20 and 40
years of age at primary diagnosis, of whom 75% (58/76)
had symptoms. 32% (46/143) of our patients were olderPage 2 of 7
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had symptoms. Only 15% of patients (21/143) were less
than 20 years old at diagnosis. Within this group five
patients were under 10 years old. Only 33% (7/21) of
patients under 20 years presented with symptoms.
Molecular diagnostics
Table 3 shows the results of molecular diagnostics in 42
patients (42/143, 29%). These were carried out in 43%
(9/21) of patients less than 20 years old, 28% (21/76) of
patients 20–40 years old and 26% (12/46) of patients
over 40 years of age. Eighteen out of 42 mutations in the
APC gene (42.9%) were detected in exon 15, six (14.3%)
were detected in exon 14, and six (14.3%) in exon 5. Exon
3 and exon 10 showed one mutation each (1/42, 2.3%).
Colorectal manifestations at primary diagnosis of FAP
Table 1 shows the colorectal findings at primary diagno-
sis, when 63% (90/143) of our patients had more than
100 polyps in the colon and 67% (96/143) between 10
and 100 polyps in the rectum. Among the patients
younger than 20 years, 57% (12/21) had more than 100
colonic polyps and 67% (14/21) had between 10 and 100
rectal polyps. Patients between the age of 20 and 40 years
had the highest prevalence of rectal polyps. In 79% (60/
76) of this age group 10–100 rectal polyps could be
detected and only 1.3% (1/76) had no rectal polyps.
Among patients over 40 years of age, 24% (11/46) had no
rectal polyps but 63% (29/46) had more than 100 colonic
polyps.
Carcinomas of the colon were detected in 17% (25/143)
and rectal carcinomas in 12% (17/143). No patient
younger than 20 years had developed colorectal cancer. In
the group between 20 and 40 years old, rectal carcinoma
was detected in 21% (10/76) and colon carcinoma in
17% (13/76). In patients older than 40 years of age, 15%
(7/143) had rectal carcinoma and 50% (23/46) had
colonic carcinoma.
Extracolonic manifestations at primary diagnosis of FAP
Table 2 shows the extracolonic manifestations at primary
diagnosis. Information about the absence or presence of
desmoid tumors of the abdominal wall and the mesente-
rium was aviable in 119 patients and about retroperito-
neal desmoids in 143 patients. Desmoid tumors of the
„Bleeding and stool disorders“ on primary diagnosis of FAP (n = 143 p tients, realtive values regarding the corresponding subgroup of age)Figure 2
„Bleeding and stool disorders“ on primary diagnosis of FAP 
(n = 143 patients, realtive values regarding the corresponding 
subgroup of age)
„Non-specific symptoms“ on primary diagnosis of FAP (n = 143 patients, realtive values regarding the c rresponding sub-grou  of age)Fig re 1
„Non-specific symptoms“ on primary diagnosis of FAP (n = 
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desmoids in 11% (13/119) and retroperitoneal desmoids
in 4% (5/143). Information about the absence or pres-
ence of gastric gland polyps was aviable in 84 patients,
about duodenal polyps in 79 and about polyps of the
small bowel in 32 patients. Gastric gland polyps were
found in 46% (39/84), duodenal polyps in 33% (26/79)
and polyps of the small bowel in 22% (7/32).
No patients younger than 20 years suffered from desmoid
tumors, but in 20% (3/15) gastric gland polyps and in
13% (2/15) duodenal polyps were discovered. The high-
est incidence of desmoid tumors (29%, 18/62) was found
in the group between 20 and 40 years of age (8% abdom-
inal wall, 15% mesenteric, 5% retroperitoneal). In two
cases within this age group the diagnosis of FAP was inci-
dental because the patient presented with a desmoid
tumor of the abdominal wall. In patients between 20 and
40 years, gastric gland polyps were detected in 52% (27/
52), duodenal polyps in 31% (16/52) and polyps of the
small bowel in 14% (4/29). Only 14% (5/36) of patients
older than 40 years had desmoid tumors at primary
diagnosis of FAP (8% abdominal wall, 8% mesenteric, 2%
retroperitoneal). And in this age group 53% (9/17) had
gastric gland polyps, 67% (8/12) had duodenal polyps.
Non-specific symptoms at primary diagnosis of FAP
The commonest non-specific symptom was abdominal
pain, found in 16% (21/129) of patients. It was most
common in patients between 40 and 50 years of age, 30%
of whom had abdominal pain as predominant symptom
(6/20, figure 1). Abdominal pain occurred in 21% (19/
90) – 31% (11/36) of patients with the predominant
manifestation in the colon, 15% (14/96) – 24% (6/25) of
patients with rectal predominance and 43% (3/7) with
polyps of the small bowel (tables 1 and 2). Fatigue was
reported by 14% (18/130), loss of weight by 12% (15/
125), and bloating by 10% (13/130). Pain during defeca-
tion was only described in 0.8% (1/130). Most patients
who developed these symptoms were between 40 and 50
years old. Fatigue was related to colon carcinomas in 31%
(11/36) and in 29% (2/7) to a predominant
manifestation in the colon, in 29% (2/7) to polyps of the
small bowel and in 27% (7/26) to duodenal polyps.
Bloating had the highest association to 10–100 colon pol-
yps, which was 29% (2/7), and to colon carcinomas
which was 17% (6/36). Loss of weight showed a correla-
tion to carcinomas of the rectum in 29% (5/17), carcino-
mas of the colon in 17% (6/36), polyps of the small
bowel in 29% (2/7) as well as to duodenal polyps in 23%
(6/26) (table 1, 2).
It has to be mentioned that most of our patients had no
non-specific symptoms on primary diagnosis of FAP, i.e.
no abdominal pain (76%, 108/143), no fatigue (78%,
112/143), no loss of weight (77%, 110/143), no bloating
(82%, 117/143) and no pain during defecation (90%,
129/143).
Bleeding and stool disorders at primary diagnosis of FAP
In 59% (84/143) tests for fecal occult blood were positive.
Microscopic bleeding was detected in 72% (55/76) of
patients between 20 and 40 years old and 50% (23/46) of
patients older than 40 years of age. In 90% (81/90) more
than 100 colon polyps, in 82% (14/17) rectal carcinomas,
in 61% (22/36) colon carcinomas, in 73% (19/26) duo-
denal polyps and in 72% (28/39) gastric gland polyps
could be detected in association to fecal occult blood.
Table 1: „Bleeding and stool disorders“, „non-specific symptoms“ and related colorectal manifestations on the primary diagnosis of 
FAP (n = 143, values in brackets are relative values)
colon rectum
10–100 polyps >100 polyps carcinoma no polyps <10 polyps 10–100 polyps carcinoma
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
total patients 7 (100) 90 (100) 36 (100) 14 (100) 25 (100) 96 (100) 17 (100)
fecal occult blood 3 (43) 81 (90) 22 (61) 7 (50) 14 (56) 61 (64) 14 (82)
colonic bleeding 2 (29) 72 (80) 17 (47) 4 (29) 12 (48) 56 (58) 13 (76)
diarrhoea 1 (14) 44 (49) 16 (44) 1 (7) 6 (24) 37 (39) 11 (65)
anemia 3 (43) 30 (33) 16 (44) 4 (29) 4 (16) 25 (26) 6 (35)
abdomial pain 2 (29) 19 (21) 11 (31) 1 (7) 6 (24) 14 (15) 3 (18)
loss of strength 2 (29) 16 (18) 11 (31) 2 (14) 2 (8) 14 (15) 4 (24)
loss of weight 1 (14) 14 (16) 6 (17) 1 (7) 3 (12) 11 (11) 5 (29)
mucous discharge 2 (29) 17 (19) 7 (19) 1 (7) 3 (12) 15 (16) 2 (12)
bloating 2 (29) 11 (12) 6 (17) 1 (7) 3 (12) 9 (9) 2 (12)
constipation - - 9 (10) 2 (6) 1 (7) 3 (12) 5 (5) 3 (18)
paradox diarrhoea - - 5 (6) 1 (3) - - 1 (4) 4 (4) 2 (12)Page 4 of 7
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(74/143). This was found in 68% (52/76) of patients
between 20 and 40 years old and in 35% (16/46) of
patients older than 40 years. Colonic bleeding was found
in 80% (72/90) of patients with more than 100 colon pol-
yps, 82% (14/17) of patients with rectal carcinoma, 64%
(61/96) of patients with 10–100 rectal polyps, 64% (25/
39) of patients with gastric gland polyps and 64% (25/39)
of those with duodenal polyps. 23% (33/143) of our
patients suffered from anemia, 21% (16/76) of patients
between 20 and 40 years, and 17% (8/46) of patients
older than 40 years of age. Anemia was found in 44% (16/
36) of patients with colon carcinoma, 35% (11/17) of
patients with rectal carcinoma and 43% (3/7) of those
with polyps of the small bowel. Diarrhea was reported in
31% (45/143). 42% (32/76) of patients between 20 and
40 years but only in 24% (11/46) older than 40 years suf-
fered from this symptom. Diarrhea showed an association
to rectal carcinomas in 65% (11/17), more than 100
colon polyps in 49% (44/90), duodenal polyps in 46%
(12/26) and polyps of the small bowel in 43% (3/7)
(tables 1 and 2). 13% (19/143) of the patients reported
mucous stools, 6% (9/143) constipation and 3% (5/143)
alternating bowel habit. These were the least frequent
stool and bleeding disorders in our sample (figure 2).
Discussion
Most patients with FAP (80%) will be detected by more or
less specific symptoms of colorectal disorders which lead
to further diagnostic evaluation. Prior to the mid-nineties,
when there was no FAP register, families of patients with
FAP underwent no routine molecular screening, nor any
further specific clinical surveillance. The diagnosis of FAP
was verified in 29% of patients by molecular diagnostics,
which became available for routine clinical use in the
1990s. The disperson of APC mutations in our study was
similar to evaluations concerning other patient popula-
tions [15]. Our study also demonstrates the importance of
clinical FAP registers, with systematic family screening to
identify presymptomatic carriers with APC gene muta-
tions [16,17]. Recent evaluations of physicians' awareness
Table 2: „Bleeding and stool disorders“, „non-specific symptoms“ and related extracolonic manifestations on primary diagnosis of 








abdominal wall mesenteric retroperitoneal
n (%) n (%) n (%) n (%) n (%) n (%)
total patients 8 (100) 13 (100) 5 (100) 39 (100) 26 (100) 7 (100)
fecal occult blood 4 (50) 9 (69) 4 (80) 28 (72) 19 (73) 4 (57)
colonic bleeding 4 (50) 9 (69) 4 (80) 25 (64) 15 (58) 2 (29)
diarrhoea 3 (38) 4 (30) 1 (20) 16 (41) 12 (46) 3 (43)
anemia 2 (25) 1 (8) - - 10 (26) 9 (35) 4 (57)
abdomial pain - - - - - - 8 (21) 6 (23) 3 (43)
loss of strength 1 (13) - - - - 7 (18) 7 (27) 2 (29)
loss of weight - - - - - - 5 (12) 6 (23) 2 (29)
mucous discharge - - 5 (39) 1 (20) 7 (18) 5 (19) 1 (14)
bloating - - - - - - 4 (10) 3 (12) 1 (14)
constipation - - - - - - 1 (3) 1 (4) - -
paradox diarrhoea - - - - - - - - 1 (4) - -
Table 3: Distribution of age related mutations in the APC gene 
exons of patients which underwent molecular diagnostics (n = 
42)
age; years
<20 20–40 >40 n %
Exon 1
Exon 2
Exon 3 1 1 2.3
Exon 4 2 1 3 7.1
Exon 5 2 3 1 6 14.3
Exon 6 2 2 4.8
Exon 7
Exon 8 1 1 2 4.8
Exon 9
Exon 10 1 1 2.3
Exon 11
Exon 12
Exon 13 3 3 7.1
Exon 14 2 3 1 6 14.3
Exon 15 5 7 6 18 42.9Page 5 of 7
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need for information concerning the availability and
appropriate use of these tests [18]. In principle, genetic
testing of index patients and their offspring can be carried
out without using a register, but the lack of awareness and
possibly the financial costs prevent an effective applica-
tion of existing knowledge and expertise.
Most patients in our hospital were diagnosed between age
20 and 40 (53%). In 75% (57/76) the diagnosis was made
clinically. They mainly presented with fecal occult blood
(50%), colonic bleeding (68%) and diarrhea (42%). Rec-
tal polyps were present in 98.7% of patients in this age
group. For this reason rectoscopy, which is widely availa-
ble, should be the first-line investigation in symptomatic
patients younger than 40 years of age. Complete colonos-
copy should be supplemented if symptoms persist with-
out diagnostic findings during rectoscopy. Some patients
presented with extracolonic manifestations such as
desmoid tumors. They could be detected in 29% of
patients between 20 and 40 years old. In two patients with
desmoid tumors, FAP was diagnosed incidentally. In these
cases especially, rectoscopy should be performed to
exclude polyps. Generally, bleeding and stool disorders
were found in cases with severe manifestations in the
colon and rectum and colorectal carcinoma. There is an
ongoing discussion concerning the benefit of
colonoscopy vs. sigmoidoscopy for patients less than 40
years of age with non-acute rectal bleeding [19]. In terms
of our findings, FAP in patients younger than 40 years old
can certainly be diagnosed with rectoscopy or flexible sig-
moidoscopy. As no rectal polyps could be detected in 24%
of patients older than 40 years of age, and colon carci-
noma was found in 50%, we propose colonoscopy in
patients of this age who present with bleeding and stool
disorders. Although fecal occult blood, colonic bleeding
and diarrhea make a colorectal disease highly probable,
they are not specific for FAP and are found in other gas-
trointestinal disorders such as inflammatory bowel dis-
ease, irritable bowel syndrome and malabsorption
syndromes or infection, which must always be kept in
mind [20-22].
Non-specific symptoms were less frequent and occurred
in only 0.8–16% of our patients. They were associated
with pronounced colorectal manifestations and many
polyps of the upper gastrointestinal tract. Non-specific
symptoms were commonest in patients over 40 years old.
The incidence of colonic carcinoma was 42–50% in this
age group. We conclude that non-specific symptoms can
imply a pronounced manifestation of FAP which usually
affects patients beyond 40 years of age [12]. Non-specific
symptoms are present in other malignancies, endocrine or
neuromuscular disorders as well [23-25].
In summary, we found no symptoms specific for FAP in
our patient population. Yet it was possible to correlate
several symptoms with disease in our age groups. In a few
cases, extracolonic manifestations were the first noticea-
ble changes. Due to their young age and mostly moderate
symptoms, patients younger than 40 years of age with FAP
are not easily identifiable in routine gastrointestinal prac-
tice. In all patients who present with the gastrointestinal
symptoms we describe, the first diagnostic step should be
rectoscopy, followed by complete colonoscopy to exclude
FAP. Patients over 40 years old in whom inherited color-
ectal cancer is suspected, even without rectal manifesta-
tions, should generally undergo colonoscopy earlier than
recommended for the general population. In patients of
all age groups genetic testing should be recommended in
order to allow presymptomatic testing in their sibs and
offspring. Family members with positive tests and all per-
sons at risk from families where the mutation could not
be identified must be examined and monitored by clinical
registers.
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